1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Myeloblastic Leukemia: new trials by email Literature Review of Myeloblastic Leukemia trials Research Report on Myeloblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis Conditioning regimen: Treosulfan 42 g/m2/course or total body irradiation 12 Gray/course, Etoposide 60 mg/kg , Fludarabine 150 - Biphenotypic Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Recruiting | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 50 | 2024-07-10 | 2025-01-01 |
| Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor - Acute Lymphoblastic Leukemia, Myeloblastic Leukemia | Phase 3 | Active not recruiting | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 56 | 2022-08-23 | 2023-09-28 |
| Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia AMPHOTERICIN B - Invasive Pulmonary Aspergillosis, Lymphoblastic Leukaemia | Phase 2 | Completed | Fundació Sant Joan de Déu | 32 | 2011-10-01 | 2018-03-29 |
| Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells NK cells - Myeloblastic Leukemia | Phase 1 | Unknown | University of Bologna | 15 | 2005-10-01 | 2009-09-24 |
Leukemia, Myelomonocytic, Acute (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Leukemia, Biphenotypic, Acute (2) · Myelodysplastic Syndromes (2) · Aspergillosis (1) · Invasive Fungal Infections (1) · Invasive Pulmonary Aspergillosis (1) · Leukemia (1) · Leukemia, Myelomonocytic, Juvenile (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Mycoses (1) · Pulmonary Aspergillosis (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia, Myeloid (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Bone Marrow Diseases (2) · Bacterial Infections and Mycoses (1) · Infections (1) · Lung Diseases (1)
Abatacept (1) · Amphotericin B (1) · Calcineurin Inhibitors (1) · Etoposide (1) · liposomal amphotericin B (1) · vedolizumab (1)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology (2) · Fundació Sant Joan de Déu (1) · University of Bologna (1)
Russia (2) · Italy (1) · Spain (1)